FDA authorizes Pfizer COVID-19 vaccine for children 5 to 11

The U.S. Food and Drug Administration has authorized the emergency use of the Pfizer coronavirus vaccine for children ages 5 to 11, the agency announced Friday.

FDA said it completed a “thorough and transparent” assessment of data prior to making its decision, including feedback from an independent advisory group that favored making the COVID-19 vaccine available to this age group.

While the authorization is a big step toward protecting children against the novel virus, the Centers for Disease Control and Prevention still must provide its own recommendation before shots become available, STAT reported.

“As a mother and a physician, I know that parents, caregivers, school staff and children have been waiting for today’s authorization. Vaccinating younger children against COVID-19 will bring us closer to returning to a sense of normalcy,” acting FDA commissioner Janet Woodcock, MD, said in a statement.  “Our comprehensive and rigorous evaluation of the data pertaining to the vaccine’s safety and effectiveness should help assure parents and guardians that this vaccine meets our high standards.”

During testing, the FDA studied the safety of the vaccine in more than 3,100 children ages 5 to 11. As it stands, no serious side effects have been reported in the ongoing study. Additionally, researchers found this age group exhibited similar immune responses to those ages 16 to 25.

The administration is optimistic its authorization and transparency will make it easier for parents to decide to protect their children against the virus.

“We are confident in the safety, effectiveness and manufacturing data behind this authorization,” Peter Marks, MD, PhD, director of the FDA’s Center for Biologics Evaluation and Research, added Oct. 29. We hope this information helps build confidence of parents who are deciding whether to have their children vaccinated.”

Read the full FDA statement here.

""

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup